Alpenglow Biosciences Announces Immediate Availability of 3D Derm Score Assay for Research into complex diseases of the skin

Alpenglow Biosciences has developed the 3D Derm Score Assay to reveal the complexities of the skin microenvironment and determine the relationship between critical structures in the epidermis and dermis. These structures are pivotal in driving skin diseases like Atopic Dermatitis, Hidradenitis Suppurativa, Alopecia Areata, Prurigo Nodularis, and other conditions impacting over 7.5 million Americans. Our assay precisely identifies and quantifies tissue structures like nerves, including the fine innervation of the epidermis, along with various cell populations.

Contact us to learn more about our 3D Derm Score™ and how we can help accelerate your drug discovery and clinical programs.  3D Derm Score™ assay is for Research Use Only (RUO).  Not for use in diagnostic procedures.  

Previous
Previous

Win a $50,000 3D I/O Pro™ research grant from Alpenglow

Next
Next

Alpenglow Biosciences, Inc. Sponsors Dinner Lecture titled “Decoding Immune Exclusion and Tumor Evasion in the TME”, featuring Dr. Laura Dillon, PhD of Incendia Therapeutics